Development of a Curative Therapeutic Vaccine (TheraVac) for the Treatment of Large Established Tumors

Harnessing immune system to treat cancer requires simultaneous generation of tumor-specific CTLs and curtailment of tumor immunosuppressive environment. Here, we developed an immunotherapeutic regimen capable of eliminating large established mouse tumors using HMGN1, a DC-activating TLR4 agonist cap...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Yingjie, Yang, De, Trivett, Anna, Han, Zhen, Xin, Haiyun, Chen, Xin, Oppenheim, Joost J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660153/
https://www.ncbi.nlm.nih.gov/pubmed/29079801
http://dx.doi.org/10.1038/s41598-017-14655-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660153/
https://www.ncbi.nlm.nih.gov/pubmed/29079801
http://dx.doi.org/10.1038/s41598-017-14655-8

Ejemplares similares